Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., Exp. Cell Res., 2019, 385: 111683, doi.org/10.1016/j.yexcr.2019.111683 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., PLoS ONE, 2020, 15(11): e0241685, doi.org/10.1371/journal.pone.0241685 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Steinmann et al., J. Biol. Chem., Vol. 288, No. 31, pp. 22257–22269, August 2, 2013 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Werwein et al., Nucleic Acids Res., 2019, 47(1): 103–121, doi: 10.1093/nar/gky935 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | application note | ![]() |
||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., BMC Cancer, 2014, 14:921, doi:10.1186/1471-2407-14-921 | Link | |
PC-12 |
Rat adrenal gland cell line | ATCC CRL-1721 | Rat | other | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | F. Martorana et al., Cell Death and Disease, 2018, 9:391; DOI 10.1038/s41419-018-0429-9 | Link | |
PC-12 |
Rat adrenal gland cell line | ATCC CRL-1721 | Rat | other | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | A. Morch, Dissertation, 2019, Ernst-Moritz-Arndt Universität Greifswald | ||
PBMC |
Human CD8+ T cells isolated from peripheral blood mononuclear cells | Human | immune system | unknown | siRNA | RNA-Interference | Metafectene PRO | application note | ![]() |
||||
pBAEC |
Bovine primary aortic endothelial cells | Cow | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | Y. Riahi et al., Diabetes, Apr 2010; 59: 808 - 818 | Link | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Cogoi et al., Nucleic Acids Res., Apr 2013; 41: 4049 - 4064 | Link | |
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | |
P skin fibroblasts |
Human immortalized skin fibroblasts (patient derived) | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Benincá et al., J. Med. Genet., 2021, 58: 155–167, doi:10.1136/jmedgenet-2020-106861 | Link | ||
Omm2.5 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | |||
OLN93 |
Rat oligodendroglial cells | Rat | nervous system | unknown | adherent | siRNA | Metafectene PRO | publication | C. V. Brill, Dissertation, 2018, Charité – Universitätsmedizin Berlin | Link | |||
OLN93 |
Rat oligodendroglial cells | Rat | nervous system | unknown | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Brill et al., Scientific Reports, 7:43000, DOI: 10.1038/srep43000 | |||
OLN93 |
Rat oligodendroglial cells | Rat | nervous system | unknown | adherent | siRNA | Metafectene PRO | publication | C. V. Brill, Dissertation, 2018, Charité – Universitätsmedizin Berlin | Link | |||
OLN93 |
Rat oligodendroglial cells | Rat | nervous system | unknown | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | C. Brill et al., Scientific Reports, 7:43000, DOI: 10.1038/srep43000 | |||
OCM-3 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | |||
OCM-3 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
OCM-1 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 |